Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747641 · ClinicalTrials.gov registry record · NA
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
A NA study of Vaginal Atrophy and Atrophy, sponsored by Alma Lasers.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02747641 is a NA study of Vaginal Atrophy and Atrophy that has completed, run by Alma Lasers. The registered enrollment target is 15 participants, below the 355-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02747641, a NA study of Vaginal Atrophy and Atrophy, has completed, sponsored by Alma Lasers.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index in VVA. The clinical improvement will be assessed by patient filled Vulvovaginal Atrophy.
Conditions Studied
Interventions
- PROCEDURE Pixel CO2 Laser System
Study Locations (1)
Florida
- The Cleveland Clinic - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747641
The ClinicalTrials.gov registry entry for NCT02747641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 355-participant average among 9 other Vaginal Atrophy trials with a reported enrollment target (96% lower). The listed sponsor is Alma Lasers, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vaginal Atrophy appearing as the primary indexed condition, and to 1 intervention - of which Pixel CO2 Laser System is the first listed.
NCT02747641 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02747641 about?
NCT02747641 is a clinical study titled "Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects". The purpose of this study is to assess the use of the Alma CO2 Pixel FemiLift™ in the treatment of VulvoVaginal Atrophy (VVA) in postmenopausal female subjects. The primary endpoint is to assess the change in the vaginal dryness by means of a Visual Analogic Scale (10 cm VAS) and/or Bachmann Index i...
What is the current status of trial NCT02747641?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2017-08.
What conditions does trial NCT02747641 study?
This clinical trial studies the following conditions: Vaginal Atrophy, Atrophy, Genital Diseases, Female.
What interventions are being tested in trial NCT02747641?
The interventions under investigation include: Pixel CO2 Laser System (PROCEDURE).
Who is sponsoring clinical trial NCT02747641?
This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747641 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaginal Atrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
RECRUITING · NA
-
PRP Injections for Genitourinary Syndrome of Menopause
ACTIVE NOT RECRUITING · NA
-
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
COMPLETED · NA
-
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
RECRUITING · Phase 4
-
Postpartum Vaginal Estrogen for Breastfeeding Patients
RECRUITING · Phase 4
-
ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.